Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience have?
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience has 416 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience published?
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience has 2012 year in the ScholarIQ index.
What is the open-access status of Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience?
Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience has closed oa status in the ScholarIQ index.
What is the DOI of Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience?
The DOI for Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience is on the source record.
What is the PMID of Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience?
The PMID for Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience is on the source record.
What is the OpenAlex record for Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience?
The OpenAlex for Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience is on the source record.